BRWA
CKPT

B. Riley Wealth Advisors’s Checkpoint Therapeutics CKPT Stock Holding History

B. Riley Wealth Advisors’s Portfolio CKPT Stock Details CKPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-229,200
Closed -$493K – 1291
2024
Q2 		$493K Buy
229,200
+180,050
+366% +$321K 0.01% 826
2024
Q1 		$83.6K Sell
49,150
-114,200
-70% -$228K ﹤0.01% 1371
2023
Q4 		$374K Buy
163,350
+114,200
+232% +$249K 0.01% 957
2023
Q3 		$83.6K Buy
49,150
+4,205
+9% +$9.56K ﹤0.01% 1371
2023
Q2 		$111K Buy
44,945
+9,295
+26% +$25.4K ﹤0.01% 1423
2023
Q1 		$80.2K Buy
35,650
+16,500
+86% +$82.8K ﹤0.01% 1406
2022
Q4 		$97.9K Buy
19,150
+3,500
+22% +$25.2K ﹤0.01% 1361
2022
Q3 		$163K Buy
15,650
+5,400
+53% +$64.3K ﹤0.01% 1264
2022
Q2 		$106K Buy
10,250
+560
+6% +$7.33K ﹤0.01% 1115
2022
Q1 		$172K Buy
9,690
+40
+0.4% +$859 0.01% 1235
2021
Q4 		$301K Sell
9,650
-2,250
-19% -$74.5K 0.01% 1072
2021
Q3 		$393K Buy
11,900
+300
+3% +$8.87K 0.01% 900
2021
Q2 		$343K Buy
11,600
+2,500
+27% +$69.3K 0.01% 951
2021
Q1 		$286K Buy
9,100
+5,550
+156% +$186K 0.01% 1027
2020
Q4 		$95K Buy
3,550
+600
+20% +$15.2K 0.01% 991
2020
Q3 		$80K Buy
+2,950
New +$70.8K ﹤0.01% 904

Other funds holding CKPT

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

B. Riley Wealth Advisors's CKPT Position: Q3 2024 in Review

B. Riley Wealth Advisors sold out of Checkpoint Therapeutics (CKPT) in Q3 2024, closing a stake of 229,200 shares — an estimated $493K sold.

B. Riley Wealth Advisors first reported a position in CKPT in Q3 2020 and held it in 16 quarters. The position peaked at $493K in Q2 2024. 47 funds tracked by Wall St. Rank hold CKPT as of Q3 2024.

  • B. Riley Wealth Advisors reported no remaining Checkpoint Therapeutics position as of Q3 2024 after selling out during the quarter.
  • B. Riley Wealth Advisors sold 229,200 Checkpoint Therapeutics shares in Q3 2024, an estimated $493K.
  • B. Riley Wealth Advisors first reported a position in Checkpoint Therapeutics in Q3 2020 and held it in 16 quarters.
  • B. Riley Wealth Advisors's Checkpoint Therapeutics position peaked at $493K in Q2 2024.
  • 47 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q3 2024.

Based on B. Riley Wealth Advisors's 13F filing for Q3 2024, filed 13 Dec 2024.